Trial Details
COMPLETEDBasic Information
| Clinical ID | c1213 |
|---|---|
| Identifier | NCT05499130 |
| Trial Title | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: TEV-48574|DRUG: Placebo |
Participant Information
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
|---|---|
| City | Sun City |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-08-29 |
|---|---|
| Primary Completion Date | 2024-11-12 |
| Completion Date | 2024-11-12 |